Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HOXD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRTAP1-3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KATNBL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MYH11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTMR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGPD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMPRSS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNALI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHOJ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZAN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NT5E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDKN2AIPNL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HPS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on